vs
Side-by-side financial comparison of Agilent Technologies (A) and Evercore Inc. (EVR). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.3B, roughly 1.4× Evercore Inc.). Agilent Technologies runs the higher net margin — 17.0% vs 15.7%, a 1.2% gap on every dollar of revenue. On growth, Evercore Inc. posted the faster year-over-year revenue change (32.4% vs 7.0%). Evercore Inc. produced more free cash flow last quarter ($798.6M vs $175.0M). Over the past eight quarters, Evercore Inc.'s revenue compounded faster (48.9% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.
A vs EVR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.3B |
| Net Profit | $305.0M | $204.0M |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | 24.2% |
| Net Margin | 17.0% | 15.7% |
| Revenue YoY | 7.0% | 32.4% |
| Net Profit YoY | -4.1% | 45.2% |
| EPS (diluted) | $1.07 | $4.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.3B | ||
| Q3 25 | $1.7B | $1.0B | ||
| Q2 25 | $1.7B | $838.0M | ||
| Q1 25 | $1.7B | $699.0M | ||
| Q4 24 | $1.7B | $979.5M | ||
| Q3 24 | $1.6B | $738.4M | ||
| Q2 24 | $1.6B | $693.4M |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $204.0M | ||
| Q3 25 | $336.0M | $144.6M | ||
| Q2 25 | $215.0M | $97.2M | ||
| Q1 25 | $318.0M | $146.2M | ||
| Q4 24 | $351.0M | $140.4M | ||
| Q3 24 | $282.0M | $78.4M | ||
| Q2 24 | $308.0M | $73.8M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 24.2% | ||
| Q3 25 | 20.7% | 20.8% | ||
| Q2 25 | 18.0% | 18.0% | ||
| Q1 25 | 22.4% | 16.0% | ||
| Q4 24 | 24.0% | 21.8% | ||
| Q3 24 | 21.1% | 16.7% | ||
| Q2 24 | 23.1% | 15.9% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 15.7% | ||
| Q3 25 | 19.3% | 13.8% | ||
| Q2 25 | 12.9% | 11.6% | ||
| Q1 25 | 18.9% | 20.9% | ||
| Q4 24 | 20.6% | 14.3% | ||
| Q3 24 | 17.9% | 10.6% | ||
| Q2 24 | 19.6% | 10.6% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $4.80 | ||
| Q3 25 | $1.18 | $3.41 | ||
| Q2 25 | $0.75 | $2.36 | ||
| Q1 25 | $1.11 | $3.48 | ||
| Q4 24 | $1.23 | $3.32 | ||
| Q3 24 | $0.97 | $1.86 | ||
| Q2 24 | $1.05 | $1.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $3.0B |
| Total DebtLower is stronger | $3.0B | — |
| Stockholders' EquityBook value | $6.9B | $2.0B |
| Total Assets | $12.8B | $5.4B |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $3.0B | ||
| Q3 25 | $1.5B | $2.4B | ||
| Q2 25 | $1.5B | $1.7B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.3B | $2.4B | ||
| Q3 24 | $1.8B | $1.8B | ||
| Q2 24 | $1.7B | $1.7B |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $2.0B | ||
| Q3 25 | $6.4B | $1.8B | ||
| Q2 25 | $6.1B | $1.7B | ||
| Q1 25 | $6.0B | $1.5B | ||
| Q4 24 | $5.9B | $1.7B | ||
| Q3 24 | $5.9B | $1.6B | ||
| Q2 24 | $6.2B | $1.5B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $5.4B | ||
| Q3 25 | $12.2B | $4.4B | ||
| Q2 25 | $12.2B | $3.7B | ||
| Q1 25 | $11.9B | $3.3B | ||
| Q4 24 | $11.8B | $4.2B | ||
| Q3 24 | $11.0B | $3.6B | ||
| Q2 24 | $10.9B | $3.3B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $807.5M |
| Free Cash FlowOCF − Capex | $175.0M | $798.6M |
| FCF MarginFCF / Revenue | 9.7% | 61.6% |
| Capex IntensityCapex / Revenue | 5.2% | 0.7% |
| Cash ConversionOCF / Net Profit | 0.88× | 3.96× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $1.2B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $807.5M | ||
| Q3 25 | $362.0M | $560.9M | ||
| Q2 25 | $221.0M | $437.7M | ||
| Q1 25 | $431.0M | $-549.7M | ||
| Q4 24 | $481.0M | $686.4M | ||
| Q3 24 | $452.0M | $234.5M | ||
| Q2 24 | $333.0M | $348.5M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $798.6M | ||
| Q3 25 | $259.0M | $541.5M | ||
| Q2 25 | $107.0M | $411.7M | ||
| Q1 25 | $334.0M | $-569.3M | ||
| Q4 24 | $388.0M | $673.1M | ||
| Q3 24 | $360.0M | $226.6M | ||
| Q2 24 | $230.0M | $340.7M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 61.6% | ||
| Q3 25 | 14.9% | 51.8% | ||
| Q2 25 | 6.4% | 49.1% | ||
| Q1 25 | 19.9% | -81.4% | ||
| Q4 24 | 22.8% | 68.7% | ||
| Q3 24 | 22.8% | 30.7% | ||
| Q2 24 | 14.6% | 49.1% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 0.7% | ||
| Q3 25 | 5.9% | 1.9% | ||
| Q2 25 | 6.8% | 3.1% | ||
| Q1 25 | 5.8% | 2.8% | ||
| Q4 24 | 5.5% | 1.4% | ||
| Q3 24 | 5.8% | 1.1% | ||
| Q2 24 | 6.5% | 1.1% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 3.96× | ||
| Q3 25 | 1.08× | 3.88× | ||
| Q2 25 | 1.03× | 4.50× | ||
| Q1 25 | 1.36× | -3.76× | ||
| Q4 24 | 1.37× | 4.89× | ||
| Q3 24 | 1.60× | 2.99× | ||
| Q2 24 | 1.08× | 4.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
EVR
| Advisory Fees | $1.1B | 87% |
| Commissions And Related Revenue | $66.5M | 5% |
| Underwriting Fees | $49.5M | 4% |
| Other | $29.6M | 2% |
| Investment Management | $23.2M | 2% |
